• 1. Support The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S.3056). The bill would provide a clear solution to abusive, anti-competitive business practices that increase costs to the American health care system by impeding patient access to generic medicines. 2. Support the Centers for Medicare & Medicaid Services (CMS) Part B Drug Payment Model. 3. General support for a legislative response to projected increases in Medicare Part B premiums and the Part B deductible in 2017.

Duration: January 1, 2008 to February 28, 2018

General Issues: Health Issues, Pharmacy, Medicare/Medicaid

Spending: about $10,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)